Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA delay
Biotech
FDA extends Beren’s rare disease review after info request
Needing time to review the updates and clarifications, the FDA has pushed the decision date back to Nov. 17.
Nick Paul Taylor
May 28, 2026 10:45am
FDA delays ruling on AstraZeneca drug after negative adcomm vote
May 27, 2026 4:43am
Aldeyra dry eye disease decision hit by FDA delay
Dec 16, 2025 11:55am
FDA delays decision on Ascendis' dwarfism prospect by 3 months
Nov 26, 2025 9:45am
Denali's Hunter syndrome drug latest to be hit by FDA delay
Oct 14, 2025 8:09am
After delay, Coya receives FDA go-ahead for phase 2 ALS trial
Aug 25, 2025 11:04am